|
Primary prevention
Citations 51-60 of 558 total displayed.
|
Past content
(since Feb 1999):
|
- Editorials
"Risky Business": Ten Years Is Not a Lifetime
- Vijay Nambi and Christie M. Ballantyne
Circulation 2009;119:362-364, doi:10.1161/CIRCULATIONAHA.108.830281
[Full text]
- Editorials
Copayment Levels and Medication Adherence: Less Is More
- Niteesh K. Choudhry
Circulation 2009;119:365-367, doi:10.1161/CIRCULATIONAHA.108.829655
[Full text]
- Arrhythmia/Electrophysiology
High Efficacy of β-Blockers in Long-QT Syndrome Type 1: Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of β-Blocker Treatment "Failures"
- G. Michael Vincent, Peter J. Schwartz, Isabelle Denjoy, Heikki Swan, Candice Bithell, Carla Spazzolini, Lia Crotti, Kirsi Piippo, Jean-Marc Lupoglazoff, Elizabeth Villain, Silvia G. Priori, Carlo Napolitano, and Li Zhang
Circulation 2009;119:215-221; published online before print as doi:10.1161/CIRCULATIONAHA.108.772533
[Abstract]
[Full text]
- Vascular Medicine
Evidence for Statin Pleiotropy in Humans: Differential Effects of Statins and Ezetimibe on Rho-Associated Coiled-Coil Containing Protein Kinase Activity, Endothelial Function, and Inflammation
- Ping-Yen Liu, Yen-Wen Liu, Li-Jen Lin, Jyh-Hong Chen, and James K. Liao
Circulation 2009;119:131-138; published online before print as doi:10.1161/CIRCULATIONAHA.108.813311
[Abstract]
[Full text]
- Articles
High Efficacy of  -Blockers in Long-QT Syndrome Type 1. Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of -Blocker Treatment "Failures"
- G. Michael Vincent, Peter J. Schwartz, Isabelle Denjoy, Heikki Swan, Candice Bithell, Carla Spazzolini, Lia Crotti, Kirsi Piippo, Jean-Marc Lupoglazoff, Elizabeth Villain, Silvia G. Priori, Carlo Napolitano, and Li Zhang
Circulation published December 31, 2008, doi:10.1161/CIRCULATIONAHA.108.772533
[Abstract]
- Articles
Evidence for Statin Pleiotropy in Humans. Differential Effects of Statins and Ezetimibe on Rho-Associated Coiled-Coil Containing Protein Kinase Activity, Endothelial Function, and Inflammation
- Ping-Yen Liu, Yen-Wen Liu, Li-Jen Lin, Jyh-Hong Chen, and James K. Liao
Circulation published December 15, 2008, doi:10.1161/CIRCULATIONAHA.108.813311
[Abstract]
- Editorials
Leapfrogging Data: No Shortcuts for Safety or Efficacy Information
- Marc A. Pfeffer and Frank M. Sacks
Circulation 2008;118:2491-2494, doi:10.1161/CIRCULATIONAHA.108.821512
[Full text]
- Coronary Heart Disease
Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib and Off-Target Toxicity: A Pooled Analysis of the Rating Atherosclerotic Disease Change by Imaging With a New CETP Inhibitor (RADIANCE) Trials
- Menno Vergeer, Michiel L. Bots, Sander I. van Leuven, Dick C. Basart, Eric J. Sijbrands, Gregory W. Evans, Diederick E. Grobbee, Frank L. Visseren, Anton F. Stalenhoef, Erik S. Stroes, and John J.P. Kastelein
Circulation 2008;118:2515-2522; published online before print as doi:10.1161/CIRCULATIONAHA.108.772665
[Abstract]
[Full text]
- Epidemiology
C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men
- Paul M Ridker, Nina P. Paynter, Nader Rifai, J. Michael Gaziano, and Nancy R. Cook
Circulation 2008;118:2243-2251; published online before print as doi:10.1161/CIRCULATIONAHA.108.814251
[Abstract]
[Full text]
- Articles
Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib and Off-Target Toxicity. A Pooled Analysis of the Rating Atherosclerotic Disease Change by Imaging With a New CETP Inhibitor (RADIANCE) Trials
- Menno Vergeer, Michiel L. Bots, Sander I. van Leuven, Dick C. Basart, Eric J. Sijbrands, Gregory W. Evans, Diederick E. Grobbee, Frank L. Visseren, Anton F. Stalenhoef, Erik S. Stroes, and John J.P. Kastelein
Circulation published November 24, 2008, doi:10.1161/CIRCULATIONAHA.108.772665
[Abstract]
|
|
